Ventas Coverage Assumed by Wells Fargo at Overweight Vs Previous Rating of Equal-Weight
Ventas Analyst Ratings
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Ventas Inc(VTR.US) to Buy Rating, Raises Target Price to $71
Ventas (VTR) Was Upgraded to a Buy Rating at Wells Fargo
Mizuho Securities Initiates Ventas Inc(VTR.US) With Buy Rating, Announces Target Price $71
Mizuho Raises Price Target on Ventas to $71 From $56
Jefferies Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $73
Ventas Price Target Raised to $70.00/Share From $64.00 by Evercore ISI Group
Ventas Is Maintained at Outperform by Evercore ISI Group
Ventas Analyst Ratings
BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $70
Evercore Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $70
Raymond James Adjusts Ventas Price Target to $68 From $65
Ventas Is Maintained at Outperform by Wedbush
Wedbush Maintains Outperform on Ventas, Raises Price Target to $71
Ventas Analyst Ratings
Wedbush Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $71
Citigroup Adjusts Ventas Price Target to $72 From $59
Ventas Price Target Raised to $64.00/Share From $61.00 by Evercore ISI Group